By Sheri Kasprzak
New York, Dec. 1 - Rockeby biomed Ltd. said it has concluded a private placement of stock for A$1,575,000.
The company issued 45 million shares at A$0.035 each to a group of sophisticated investors outside of Australia.
Proceeds will be used for research and development, expansion in the U.S. and European markets and for working capital.
Based in West Perth, Western Australia, Rockeby develops tests to diagnose HIV and other viruses.
| Issuer: | Rockeby biomed Ltd.
|
| Issue: | Stock
|
| Amount: | A$1,575,000
|
| Shares: | 45 million
|
| Price: | A$0.035
|
| Warrants: | No
|
| Settlement date: | Dec. 1
|
| Stock price: | A$0.043 at close Dec. 1
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
